Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
3.050
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
3.040
-0.010 (-0.33%)
After-hours: Mar 28, 2024, 7:03 PM EDT
Ovid Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Ovid Therapeutics stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 11. The average target predicts an increase of 162.30% from the current stock price of 3.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 21, 2023.
Analyst Ratings
The average analyst rating for OVID stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +260.66% | Dec 21, 2023 |
JonesTrading | JonesTrading | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +96.72% | Jun 14, 2023 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +129.51% | May 2, 2023 |
Citigroup | Citigroup | Hold Maintains $2.4 → $2.5 | Hold | Maintains | $2.4 → $2.5 | -18.03% | Aug 29, 2022 |
Citigroup | Citigroup | Hold Maintains $4 → $2.4 | Hold | Maintains | $4 → $2.4 | -21.31% | May 20, 2022 |
Financial Forecast
Revenue This Year
455.43K
from 391.70K
Increased by 16.27%
Revenue Next Year
37.57M
from 455.43K
Increased by 8,150.01%
EPS This Year
-0.68
from -0.74
EPS Next Year
-0.04
from -0.68
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 825,300 | 56.5M | 55.7M | 84.6M | 169.1M |
Avg | 455,430 | 37.6M | 44.7M | 82.2M | 140.6M |
Low | n/a | 11.3M | 33.8M | 79.0M | 112.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 110.7% | 12,307.4% | 48.4% | 89.5% | 105.7% |
Avg | 16.3% | 8,150.0% | 18.9% | 84.0% | 71.1% |
Low | - | 2,374.6% | -10.0% | 76.7% | 36.8% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.35 | 0.82 |
Avg | -0.68 | -0.04 |
Low | -0.75 | -0.59 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.